Plastic Closure Market Size 2023 Report by Market Dynamics, Emerging Market Trends and Business Strategi - Benzinga
| 4166 Stock | TWD 35.75 0.85 2.32% |
Slightly above 61% of Orient Pharma's investor base is looking to short. The analysis of current outlook of investing in Orient Pharma Co suggests that many traders are alarmed regarding Orient Pharma's prospects. Orient Pharma's investing sentiment can be driven by a variety of factors including economic data, Orient Pharma's earnings reports, geopolitical events, and overall market trends.
Orient Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Orient daily returns and investor perception about the current price of Orient Pharma Co as well as its diversification or hedging effects on your existing portfolios.
Orient |
Plastic Closure Market Size 2023 Report by Market Dynamics, Emerging Market Trends and Business Strategi Benzinga
Read at news.google.com
 |
Orient Pharma Fundamental Analysis
We analyze Orient Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orient Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orient Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Orient Pharma is rated second in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Orient Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Orient Pharma stock to make a market-neutral strategy. Peer analysis of Orient Pharma could also be used in its relative valuation, which is a method of valuing Orient Pharma by comparing valuation metrics with similar companies.
Peers
Orient Pharma Related Equities
| 4108 | Phytohealth Corp | 2.84 | ||||
| 4102 | Yung Zip | 1.16 | ||||
| 1783 | Maxigen Biotech | 0.42 | ||||
| 8432 | Tsh Biopharmoration | 0.65 | ||||
| 4166 | Orient Pharma | 2.32 |
Additional Tools for Orient Stock Analysis
When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.